{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:30:34Z","timestamp":1781166634279,"version":"3.54.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to investigate the effects of different antiseizure medications (ASMs) and clinical treatment response on interictal electrocardiographic (ECG) repolarization indices and echocardiographic structural and functional cardiac parameters in patients with epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This single-center, prospective, cross-sectional study was conducted between August 2024 and February 2025 at the Neurology and Cardiology Departments of Siirt Training and Research Hospital. The study included 97 patients with epilepsy and 57 age- and sex-matched healthy controls. Patients were classified as drug-sensitive or drug-resistant based on the International League Against Epilepsy (ILAE) criteria. While both monotherapy and polytherapy users were included in clinical comparisons, subgroup analyses by ASM type involved only monotherapy patients. ECG and echocardiographic parameters were assessed. Group comparisons and correlation analyses were performed using analysis of variance (ANOVA), chi-square test, and Pearson correlation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant differences in demographic or interictal ECG repolarization indices were found between the drug-sensitive, drug-resistant, and control groups (<jats:italic>P<\/jats:italic>\u2009&amp;gt;\u20090.05). Both epilepsy groups had significantly higher left atrial volum index (LAVi) compared to controls (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), while A velocity and lateral E\u2032 were significantly lower. Carbamazepine (CBZ) group showed the highest LAVi, though without correlation to treatment duration. In contrast, valproic acid (VPA) and levetiracetam (LEV) groups exhibited significant positive correlations between treatment duration and LAVi (r\u2009=\u20090.776, <jats:italic>P<\/jats:italic>\u2009=\u20090.002; r\u2009=\u20090.571, <jats:italic>P<\/jats:italic>\u2009=\u20090.002, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Treatment with ASMs in epilepsy is associated with left atrial enlargement, particularly with CBZ. The absence of interictal ECG repolarization differences suggests that isolated assessments may be insufficient, supporting long-term cardiac monitoring in epilepsy management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1617114","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:32:16Z","timestamp":1760592736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac abnormalities and repolarization variability in epilepsy: influence of antiseizure medications and treatment response"],"prefix":"10.3389","volume":"12","author":[{"given":"Cagdas","family":"Kaynak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Ertekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Attila","family":"Erkuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100696","DOI":"10.1016\/j.ebr.2024.100696","article-title":"The epileptic heart syndrome: epidemiology, pathophysiology and clinical detection","volume":"27","author":"Verrier","year":"2024","journal-title":"Epilepsy Behav Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1528-1167.2010.02571.x","article-title":"Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death","volume":"51","author":"Surges","year":"2010","journal-title":"Epilepsia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/epi.16966","article-title":"Epileptic heart: a clinical syndromic approach","volume":"62","author":"Verrier","year":"2021","journal-title":"Epilepsia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100668","DOI":"10.1016\/j.ebr.2024.100668","article-title":"The epileptic heart: cardiac comorbidities and complications of epilepsy. Atrial and ventricular structure and function by echocardiography in individuals with epilepsy - from clinical implications to individualized assessment","volume":"26","author":"Loureiro","year":"2024","journal-title":"Epilepsy Behav Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1528-1157.2000.tb00207.x","article-title":"EKG abnormalities during partial seizures in refractory epilepsy","volume":"41","author":"Nei","year":"2000","journal-title":"Epilepsia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/jcm12124098","article-title":"Electrocardiogram changes in the postictal phase of epileptic seizure: results from a prospective study","volume":"12","author":"Gigli","year":"2023","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40263-025-01163-x","article-title":"Cardiovascular effects of antiseizure medications for epilepsy","volume":"39","author":"Nei","year":"2025","journal-title":"CNS Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100738","DOI":"10.1016\/j.ebr.2024.100738","article-title":"Management recommendations to reduce cardiac risk in chronic epilepsy","volume":"29","author":"Pang","year":"2024","journal-title":"Epilepsy Behav Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14740338.2022.2023128","article-title":"Cardiac adverse effects of antiseizure medications","volume":"21","author":"Zaccara","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"B10","doi-asserted-by":"publisher","first-page":"101868","DOI":"10.1016\/j.cpcardiol.2023.101868","article-title":"Epilepsy-heart syndrome: incidence and clinical outcomes of cardiac complications in patients with epilepsy","volume":"48","author":"Bucci","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/epi.18577","article-title":"Left atrial remodeling in epilepsy: a comparative echocardiographic study of left atrial emptying fraction and left atrial volumetric index in patients with epilepsy","author":"Duran","year":"2025","journal-title":"Epilepsia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/ejechocard\/jep153","article-title":"Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis","volume":"11","author":"Teo","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e3885","DOI":"10.5812\/ijp.3885","article-title":"Oxidative status in epileptic children using carbamazepine","volume":"25","author":"Tutanc","year":"2015","journal-title":"Iran J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eplepsyres.2003.10.012","article-title":"Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy","volume":"57","author":"Persson","year":"2003","journal-title":"Epilepsy Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"112021","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: a new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jsps.2022.12.001","article-title":"A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid","volume":"31","author":"Safdar","year":"2023","journal-title":"Saudi Pharm J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e007071","DOI":"10.1161\/CIRCEP.118.007071","article-title":"HDAC (histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice","volume":"12","author":"Scholz","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.26355\/eurrev_202303_31544","article-title":"A novel marker to predict cardiac arrhythmia in epilepsy patients: frontal QRS-T angle","volume":"27","author":"Duzgun","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.hrthm.2021.11.013","article-title":"QT Prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality","volume":"19","author":"Chahal","year":"2022","journal-title":"Heart Rhythm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/epi.18502","article-title":"Intersection of epilepsy and cardiac health: insights from electrocardiography and syndromic associations","author":"Akyuz","year":"2025","journal-title":"Epilepsia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.seizure.2025.01.009","article-title":"Association between anti-seizure medications and cardiac arrhythmias in patients undergoing ambulatory electroencephalographic and electrocardiographic monitoring","volume":"125","author":"Ha","year":"2025","journal-title":"Seizure"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4274\/ArchEpilepsy.2024.24129","article-title":"Positive bias in the prolonged QT interval in epilepsy is related to the calculation method rather than specific anti-seizure medications","volume":"31","author":"Al-Nimer","year":"2025","journal-title":"Arch Epilepsy"},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/jcdd10100433","article-title":"Mapping of neuro-cardiac electrophysiology: interlinking epilepsy and arrhythmia","volume":"10","author":"Senapati","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"829365","DOI":"10.1155\/2011\/829365","article-title":"Evaluation of heart rate variation analysis during rest and tilting in patients with temporal lobe epilepsy","volume":"2011","author":"Ansakorpi","year":"2011","journal-title":"Neurol Res Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5472\/marumj.1244552","article-title":"Evaluation of autonomic nervous system functions by using tilt table test and heart rate variability in epileptic children","volume":"36","author":"Redjepov","year":"2023","journal-title":"Marmara Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e008435","DOI":"10.1161\/JAHA.117.008435","article-title":"Association of left atrial function index with atrial fibrillation and cardiovascular disease: the framingham offspring study","volume":"7","author":"Sardana","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.amjcard.2008.02.099","article-title":"Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the heart and soul study)","volume":"102","author":"Ristow","year":"2008","journal-title":"Am J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1265037","DOI":"10.3389\/fneur.2023.1265037","article-title":"Association between left atrial volume index and infarct volume in patients with ischemic stroke","volume":"14","author":"Homssi","year":"2023","journal-title":"Front Neurol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1617114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:32:17Z","timestamp":1760592737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1617114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2025.1617114"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1617114","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1617114"}}